✦ LIBER ✦

Flow-cytometric detection of minimal residual disease with atypical antigen combinations in patients with de novo acute myeloid leukemia

✍ Scribed by E. Plata; H. Choremi-Papadopoulou; V. Viglis; X. Yataganas

Book ID: 105990000
Publisher: Springer
Year: 2000
Tongue: English
Weight: 79 KB
Volume: 79
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770000183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flow cytometric determination of atypica

Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease

✍ Dr. Johannes Drach; Doris Drach; Herta Glassl; Claus Gattringer; Heinz Huber 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan

✍ Hiroto Narimatsu; Masaki Iino; Takuji Ichihashi; Toshiya Yokozawa; Masaya Hayaka 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 205 KB

Detection of minimal residual disease in

Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies

✍ Nobutaka Imamura; Atsushi Kuramoto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations

✍ Dana Dvorakova; Zdenek Racil; Ivana Jeziskova; Ivo Palasek; Marketa Protivankova 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

The use of receiver operating characteri

The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

✍ Adhra Al-Mawali; David Gillis; Ian Lewis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

## Abstract ## Background: Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and rela